Technology

Generosity from anonymous donors will support research and aid in the development of new treatments for hard-to-treat or incurable diseases, to the benefit of patients everywhere.

UVA Licensing & Ventures Group helps UVA researchers secure patents for their inventions and launch start-up companies.

A new way of thinking about Alzheimer's disease has yielded a UVA research discovery that could be the key to stopping the cognitive decline seen in Alzheimer's and other neurodegenerative diseases.

Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.

One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth.

The plant in Chesterfield County, Virginia, is the result of university-generated knowledge and sustained basic research. UVA faculty are engaged in a Fusion Innovation Hub to build out the ecosystem.

A statewide biopharma boom is fueled by talent emerging from Virginia's universities, which provide a steady pipeline of specialized labor.

The Virginia Catalyst Fund encourages collaboration with over 30 industry partners in collaboration with Virginia universities, including UVA.

Discover the University's contributions to Virginia through a series of compelling, vignette-style highlights presented in this first edition report. Understand UVA as an engine for inclusive economic growth by exploring the initiatives that…

Discover the University's contributions to Virginia through a series of compelling, vignette-style highlights presented in this first edition report. Understand UVA as an engine for inclusive economic growth by exploring the initiatives that…

ITHRIV includes the University of Virginia, Inova Health System, Virginia Tech and Carilion Clinic as partners, with the Center for Open Science and UVA’s Licensing & Ventures Group as affiliates.